Stent Versus Conservative Treatment in Patients With Deep Venous Obstruction

NCT ID: NCT03026049

Last Updated: 2022-04-08

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

NA

Total Enrollment

65 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-03-09

Study Completion Date

2021-10-07

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Patients will be randomised between deep venous stenting or conservative management

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Deep-Venous Thrombosis Deep Venous Stenting Randomized Clinical Trial

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

deep venous stent

Patients will receive deep venous stenting in the iliaco(femoral) region

Group Type ACTIVE_COMPARATOR

deep venous stenting

Intervention Type DEVICE

Deep venous stent

conservative managment

Conservative management of complaints

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

deep venous stenting

Deep venous stent

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age \>18 years
* Meet criteria for PTS or
* Patients with May Thurner syndrome on additional imaging
* Life expectancy of more than one year
* Deep venous thrombosis \> 1 year
* Signed informed consent

Exclusion Criteria

* Previous intervention of central veins (inferior vena cava, iliac veins, common femoral vein) on the affected limb
* Known pregnancy
* Inability to answer Dutch QoL questionnaires or limited communication in Dutch (written and spoken)
* Contra-indication for prolonged anticoagulant treatment
* Recent, \<1 year, deep venous thrombosis or pulmonary Embolism
* Known contrast allergy
* Known dialysis or renal insufficiency needing additional preparation for injection of contrast
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Maastricht University Medical Center

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Maastricht university medical center

Maastricht, Limburg, Netherlands

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Netherlands

References

Explore related publications, articles, or registry entries linked to this study.

Flumignan RL, Nakano LC, Flumignan CD, Baptista-Silva JC. Angioplasty or stenting for deep venous thrombosis. Cochrane Database Syst Rev. 2025 Feb 19;2(2):CD011468. doi: 10.1002/14651858.CD011468.pub2.

Reference Type DERIVED
PMID: 39968829 (View on PubMed)

Shekarchian S, Van Laanen J, Esmaeil Barbati M, Vleugels MJ, Nelemans P, Razavi MK, Mees B, Jacobs MJ, Jalaie H. Editor's Choice - Quality of Life after Stenting for Iliofemoral Venous Obstruction: A Randomised Controlled Trial with One Year Follow Up. Eur J Vasc Endovasc Surg. 2023 Nov;66(5):678-685. doi: 10.1016/j.ejvs.2023.07.044. Epub 2023 Jul 28.

Reference Type DERIVED
PMID: 37517579 (View on PubMed)

van Vuuren TM, van Laanen JHH, de Geus M, Nelemans PJ, de Graaf R, Wittens CHA. A randomised controlled trial comparing venous stenting with conservative treatment in patients with deep venous obstruction: research protocol. BMJ Open. 2017 Sep 11;7(9):e017233. doi: 10.1136/bmjopen-2017-017233.

Reference Type DERIVED
PMID: 28893753 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

RCT DVO

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.